|
BJDX Bluejay Diagnostics Inc 1704287 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-1,919,241.00 |
| Balance Sheet |
|
Current Assets
|
$3,967,460.00 |
|
Assets
|
$5,598,603.00 |
|
Current Liabilities
|
$1,413,919.00 |
|
Liabilities
|
$1,417,408.00 |
|
Equity
|
$4,181,195.00 |
|
Shares Out
|
1034715.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,589,200.00 |
|
Investing Cash Flow
|
$-15,314.00 |
| Market Analysis |
Market Cap
|
$962,284.95 |
|
Price
|
$0.86 |
|
BVPS
|
4.04 |
|
PB
|
0.23 |
|
EPS
|
-1.95 |
|
FCF
|
$-1,608,189.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:46 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:47 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BJDX documents filed with the SEC.
BJDX Filings
Clear
